TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/26/26 16:55 | 2/24/26 | VIR | Vir Biotechnology, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | O'Byrne Jason | CA | O | EVP,CFO | S | -16 | 9.53 | 0 | -2 | -1 | 163 | D | ||||||||||||||
2/24/26 19:12 | 2/23/26 | VIR | Vir Biotechnology, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | O'Byrne Jason | CA | O | EVP,CFO | S.d | -16 | 7.45 | 0 | -2 | -1 | 164 | D | ||||||||||||||
11/18/25 14:47 | 11/17/25 | VIR | Vir Biotechnology, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | O'Byrne Jason | CA | O | EVP,CFO | S | -38 | 5.56 | 0 | -7 | -6 | 111 | D | ||||||||||||||
2/8/22 19:27 | 2/8/22 | CRBU | Caribou Biosciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | O'Byrne Jason | CA | O | CFO | M.d | 100 | 4.11 | 0 | 24 | New | 24 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |